Orange Book product · Brand (NDA)
ERAXIS
ANIDULAFUNGIN
Brand (NDA)NDA 021632RX VICURON HOLDINGS
At a glance
Nov 14, 2006
Approved
Brand (NDA)
Application
Not listed
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Nov 14, 2006
19 yr 11 mo ago
Today
Pharmaceutical detail
Active ingredient
ANIDULAFUNGIN
Strength
100MG/VIAL
Dosage form
POWDER
Route
INTRAVENOUS
TE code
Not listed
Application
NDA 021632
Product number
002
Marketing status
RX
Reference listed drug (RLD)
Yes
Reference standard (RS)
Yes
Active-ingredient family
View full familyThis is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
